SEC filings
Colgate-Palmolive (CL)
Recent filings Colgate-Palmolive made with the SEC, newest first. Most have a short AI-generated summary, and every one links to the original.
CIK 0000021665All filings on SEC.gov
10-QQuarterly report
Quarterly report
Colgate-Palmolive reported third-quarter 2026 net sales of $5.37 billion, up from $5.13 billion a year earlier, and net income attributable to the company of $751 million, or $0.94 per diluted share, versus $735 million, or $0.91 per…
8-KCurrent report
Results of Operations and Financial Condition
Colgate-Palmolive reported third-quarter 2026 results, with net sales up 4.6% and organic sales up 3.6%, and narrowed its full-year sales guidance while raising gross profit margin and Base Business EPS guidance. …
10-QQuarterly report
Quarterly report
Colgate-Palmolive reported second-quarter 2026 net sales of $5.36 billion, up from $5.11 billion a year earlier, while net income attributable to the company fell to $693 million from $743 million and diluted earnings per share slipped to…
8-KCurrent report
Results of Operations and Financial Condition
Colgate-Palmolive reported second-quarter 2026 net sales of $5.36 billion, up 4.9% year over year, with organic sales up 2.4%, GAAP diluted EPS down 5% to $0.86 and Base Business EPS up 8% to $0.99. …
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.
Follow Colgate-Palmolive in Readster
Add Colgate-Palmolive to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.
No credit card. When the trial ends, you move to Readster Free unless you subscribe.